Original language | English (US) |
---|---|
Pages (from-to) | 5425-5430 |
Number of pages | 6 |
Journal | Blood Advances |
Volume | 4 |
Issue number | 21 |
DOIs | |
State | Published - Nov 10 2020 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia. / Mangaonkar, Abhishek A.; Reichard, Kaaren K.; Binder, Moritz et al.
In: Blood Advances, Vol. 4, No. 21, 10.11.2020, p. 5425-5430.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia
AU - Mangaonkar, Abhishek A.
AU - Reichard, Kaaren K.
AU - Binder, Moritz
AU - Coltro, Giacomo
AU - Lasho, Terra L.
AU - Carr, Ryan M.
AU - Chiu, April
AU - Negron, Vivian
AU - Hefazi, Mehrdad
AU - Anagnostou, Theodora
AU - Timm, Michael M.
AU - Hiebert, James W.
AU - Villasboas, Jose C.
AU - Gonsalves, Wilson I.
AU - Gangat, Naseema
AU - Shah, Mithun
AU - Alkhateeb, Hassan B.
AU - Al-Kali, Aref
AU - Elliott, Michelle A.
AU - Begna, Kebede H.
AU - Wolanskyj-Spinner, Alexandra P.
AU - Litzow, Mark R.
AU - Hogan, William J.
AU - Ansell, Stephen M.
AU - Pardanani, Animesh
AU - Tefferi, Ayalew
AU - Patnaik, Mrinal M.
N1 - Funding Information: The authors acknowledge the services and expertise of the Pathology Research Core, the Immune Monitoring Core, and the Metabolomics Resource Core of Mayo Clinic (Rochester, MN). The authors also acknowledge the technical input of Hyo Jin Kim for the flow cytometry experiments. This work was supported, in part, by the American Society of Clinical Oncology Conquer Cancer Foundation–sponsored Young Investigator Award, the Eagles 5th District Cancer Telethon Pilot Investigator Award, and the Mayo Clinic Hematology Small Grants Program Grant (A.A.M.), as well as grant UL1TR002377 from the National Institutes of Health, National Center for Advancing Translational Sciences. Results and views do not necessarily reflect the views of the funding agencies. Funding Information: This work was supported, in part, by the American Society of Clinical Oncology Conquer Cancer Foundation–sponsored Young
PY - 2020/11/10
Y1 - 2020/11/10
UR - http://www.scopus.com/inward/record.url?scp=85096899217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096899217&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2020002415
DO - 10.1182/bloodadvances.2020002415
M3 - Article
C2 - 33152058
AN - SCOPUS:85096899217
SN - 2473-9529
VL - 4
SP - 5425
EP - 5430
JO - Blood advances
JF - Blood advances
IS - 21
ER -